Item
Caffeine Anhydrous (4200)
Caffeine- 98.5%~101.5%
Coffee
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| CSPC INNOVATION PHARMACEUTICAL | No. 36 Fuqiang Western Rd Luancheng Cty Shijazhaung City, Hebei Province NA CHN |
| Hebei Guangxiang Pharmaceutical Co. Ltd. | The East of Jingliu Road, West of Cangzhou Lingang Cangzhou City, HE 061100 CHN |
| Prinova USA | 6525 Muirfield Drive. Hanover Park, IL 60133 |
| Shandong Xinhua Pharmaceutical Co., Ltd. | East Chemical Zone of Zibo High and New Technologic Devolpment Zone Zibo City, Shandong Province xxx CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Recall/Emergency/Contact List | CSPC INNOVATION PHARMACEUTICAL | 2023 contact info.pdf | 12/9/2024 | 12/9/2025 |
| 3rd Party Audit Certificate | CSPC INNOVATION PHARMACEUTICAL | 3rd Party Food Safety Certificate - 2024-12-06T094938.677.pdf | 9/30/2024 | 10/31/2025 |
| GFSI Certificate | CSPC INNOVATION PHARMACEUTICAL | 3rd Party Food Safety Certificate - 2024-12-06T121517.390.pdf | 9/30/2024 | 10/31/2025 |
| HACCP | Shandong Xinhua Pharmaceutical Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 8/10/2023 | 8/9/2026 |
| HACCP | Hebei Guangxiang Pharmaceutical Co. Ltd. | 3rd party-Haccp doc - Prinova.pdf | 10/12/2023 | 10/11/2026 |
| HACCP | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 1/17/2024 | 1/16/2027 |
| 3rd Party Audit Corrective Action Plan | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/31/2025 |
| 3rd Party Audit Report | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/31/2025 |
| Bioterrorism Letter | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2026 |
| Food Defense Plan Statement | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2026 |
| GFSI Audit Report | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2026 |
| GFSI Corrective Action | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2026 |
| HACCP Plan (Facility) | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2026 |
| HARPC Food Safety Plan (Facility) | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2027 |
| HARPC Food Safety Plan (Item) | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2027 |
| CA Transparency Act | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2026 |
| CTPAT | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2025 |
| Environmental Policy | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2025 |
| Ethical Code of Conduct | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2026 |
| FDA Registration | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/31/2025 |
| Organizational Chart | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2025 |
| Recall Plan | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2025 |
| Supplier Approval Program Statement | CSPC INNOVATION PHARMACEUTICAL | 3rd party-Haccp doc - Prinova.pdf | 12/6/2024 | 12/6/2025 |
| HARPC Food Safety Plan (Item) | Shandong Xinhua Pharmaceutical Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 1/3/2025 | 1/3/2028 |
| Gluten | CSPC INNOVATION PHARMACEUTICAL | Allergen - 2024-12-06T122342.608.pdf | 3/8/2024 | 3/8/2026 |
| Allergen Control Policy | CSPC INNOVATION PHARMACEUTICAL | Allergen - 2024-12-06T125915.569.pdf | 3/8/2024 | 3/8/2026 |
| Gluten | Shandong Xinhua Pharmaceutical Co., Ltd. | Allergen - 2025-02-26T130902.701.pdf | 2/26/2025 | 2/26/2027 |
| Allergens EU/UK | CSPC INNOVATION PHARMACEUTICAL | Allergens EU/UK.pdf | 12/6/2024 | 12/6/2026 |
| Allergens | CSPC INNOVATION PHARMACEUTICAL | Allergens.pdf | 6/4/2024 | 6/4/2026 |
| Allergens | Shandong Xinhua Pharmaceutical Co., Ltd. | Allergens.pdf | 11/13/2024 | 11/13/2026 |
| Allergens | Hebei Guangxiang Pharmaceutical Co. Ltd. | Allergens.pdf | 2/14/2025 | 2/14/2027 |
| CoA Sample | Shandong Xinhua Pharmaceutical Co., Ltd. | Approved COA Template - 2023-08-09T161358.450.pdf | 9/13/2023 | 9/12/2025 |
| CoA Sample | Hebei Guangxiang Pharmaceutical Co. Ltd. | Approved COA Template - 2024-09-13T150632.897.pdf | 1/29/2024 | 1/28/2026 |
| CoA Sample | CSPC INNOVATION PHARMACEUTICAL | Approved COA Template - 2025-01-07T124115.966.pdf | 6/6/2023 | 6/5/2025 |
| WADA/NSF/NFL Statement | CSPC INNOVATION PHARMACEUTICAL | Banned Substance - 2025-02-28T131258.285.pdf | 2/28/2025 | 2/28/2027 |
| Gluten | Hebei Guangxiang Pharmaceutical Co. Ltd. | Caffeine anhydrous - Hebei Guangxiang - Allergen status.pdf | 4/29/2025 | 4/29/2027 |
| Insurance | CSPC INNOVATION PHARMACEUTICAL | Certificate of Insurance doc - Prinova 2024.pdf | 10/1/2024 | 10/1/2025 |
| Residual Statement | Shandong Xinhua Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2023-08-09T163422.885.pdf | 9/13/2022 | 9/13/2023 |
| Heavy Metal | CSPC INNOVATION PHARMACEUTICAL | Contaminants and Impurities - 2024-05-20T093225.986.pdf | 3/8/2024 | 3/8/2026 |
| Pesticide | CSPC INNOVATION PHARMACEUTICAL | Contaminants and Impurities - 2024-05-20T093225.986.pdf | 3/8/2024 | 3/8/2026 |
| Melamine | CSPC INNOVATION PHARMACEUTICAL | Contaminants and Impurities - 2024-12-06T124508.022.pdf | 3/8/2024 | 3/8/2025 |
| Heavy Metal | Hebei Guangxiang Pharmaceutical Co. Ltd. | Contaminants and Impurities - 2025-02-14T153651.231.pdf | 1/27/2024 | 1/26/2026 |
| Pesticide | Shandong Xinhua Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2025-02-17T141210.021.pdf | 9/13/2023 | 9/12/2025 |
| Heavy Metal | Shandong Xinhua Pharmaceutical Co., Ltd. | Contaminants and Impurities - 2025-02-21T153755.253.pdf | 2/21/2025 | 2/21/2027 |
| Country of Origin EU/UK | CSPC INNOVATION PHARMACEUTICAL | Country of Origin EU/UK.pdf | 12/6/2024 | 12/6/2027 |
| Country of Origin | Hebei Guangxiang Pharmaceutical Co. Ltd. | Country of Origin.pdf | 2/15/2023 | 2/14/2026 |
| Country of Origin | CSPC INNOVATION PHARMACEUTICAL | Country of Origin.pdf | 1/18/2024 | 1/17/2027 |
| Country of Origin | Shandong Xinhua Pharmaceutical Co., Ltd. | Country of Origin.pdf | 11/13/2024 | 11/13/2027 |
| California Prop. 65 | Hebei Guangxiang Pharmaceutical Co. Ltd. | Dietary Status (78).pdf | 1/29/2024 | 1/28/2026 |
| Dietary Supplement Questionnaire | CSPC INNOVATION PHARMACEUTICAL | Dietary Supplement Questionnaire.pdf | 7/7/2023 | 7/6/2024 |
| HACCP Process Flow Diagram | CSPC INNOVATION PHARMACEUTICAL | Flow Chart - 2023-12-05T135318.661.pdf | 11/15/2023 | 11/14/2025 |
| HACCP Process Flow Diagram | Shandong Xinhua Pharmaceutical Co., Ltd. | Flow Chart - 2024-10-07T102116.538.pdf | 9/13/2023 | 9/12/2025 |
| HACCP Process Flow Diagram | Hebei Guangxiang Pharmaceutical Co. Ltd. | Flow Chart - 2025-02-14T154017.489.pdf | 1/27/2024 | 1/26/2026 |
| FSVP Assessment Form | Hebei Guangxiang Pharmaceutical Co. Ltd. | FSVP Assessment Form.pdf | 8/9/2024 | 8/9/2025 |
| FSVP Assessment Form | Shandong Xinhua Pharmaceutical Co., Ltd. | FSVP Assessment Form.pdf | 11/18/2024 | 11/18/2025 |
| FSVP Assessment Form | CSPC INNOVATION PHARMACEUTICAL | FSVP Assessment Form.pdf | 3/5/2025 | 3/5/2026 |
| GMO | CSPC INNOVATION PHARMACEUTICAL | GMO - 2024-12-06T115653.058.pdf | 3/8/2024 | 3/8/2026 |
| GMO | Shandong Xinhua Pharmaceutical Co., Ltd. | GMO - 2025-02-21T154658.892.pdf | 2/21/2025 | 2/21/2027 |
| GMO | Hebei Guangxiang Pharmaceutical Co. Ltd. | GMO - 2025-03-05T154310.933.pdf | 3/5/2025 | 3/5/2027 |
| Halal | Hebei Guangxiang Pharmaceutical Co. Ltd. | Halal Certificate - 2023-10-12T151838.580.pdf | 6/16/2022 | 9/30/2025 |
| Halal | Shandong Xinhua Pharmaceutical Co., Ltd. | Halal Certificate - 2024-10-09T125017.432.pdf | 8/15/2024 | 9/30/2026 |
| Halal | CSPC INNOVATION PHARMACEUTICAL | Halal Certificate - 2025-02-14T121706.424.pdf | 3/15/2023 | 3/17/2027 |
| Label Sample | Hebei Guangxiang Pharmaceutical Co. Ltd. | Hebei Guangxiang - Caffeine anhydrous - Packaging declaration.pdf | 6/3/2025 | 6/3/2026 |
| Food Contact Packaging Certificate of Compliance | Hebei Guangxiang Pharmaceutical Co. Ltd. | Hebei Guangxiang - Caffeine anhydrous - Packaging declaration.pdf | 6/3/2025 | 6/3/2027 |
| Sewage Statement | CSPC INNOVATION PHARMACEUTICAL | IR_ETO_Sewer Sludge (8).pdf | 7/12/2024 | 7/12/2026 |
| Item Questionnaire | Hebei Guangxiang Pharmaceutical Co. Ltd. | Item Questionnaire.pdf | 3/9/2023 | 3/8/2026 |
| Item Questionnaire | CSPC INNOVATION PHARMACEUTICAL | Item Questionnaire.pdf | 9/13/2024 | 9/13/2027 |
| Item Questionnaire | Shandong Xinhua Pharmaceutical Co., Ltd. | Item Questionnaire.pdf | 11/13/2024 | 11/13/2027 |
| Kosher | Hebei Guangxiang Pharmaceutical Co. Ltd. | Kosher Certificate - 2023-10-12T153340.298.pdf | 9/5/2023 | 8/31/2025 |
| Kosher | CSPC INNOVATION PHARMACEUTICAL | Kosher Certificate - 2024-09-20T134744.301.pdf | 8/25/2024 | 8/31/2025 |
| Kosher | Shandong Xinhua Pharmaceutical Co., Ltd. | Kosher Certificate - 2025-03-19T132925.388.pdf | 12/11/2024 | 12/31/2025 |
| National Bioengineered Food Disclosure Standard (Simplified) | Hebei Guangxiang Pharmaceutical Co. Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 2/15/2023 | 2/14/2026 |
| National Bioengineered Food Disclosure Standard (Simplified) | Shandong Xinhua Pharmaceutical Co., Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 8/10/2023 | 8/9/2026 |
| National Bioengineered Food Disclosure Standard (Simplified) | CSPC INNOVATION PHARMACEUTICAL | National Bioengineered Food Disclosure Standard (Simplified).pdf | 12/6/2024 | 12/6/2027 |
| Nutrition | CSPC INNOVATION PHARMACEUTICAL | Nutrition.pdf | 12/2/2022 | 12/1/2025 |
| Nutrition | Hebei Guangxiang Pharmaceutical Co. Ltd. | Nutrition.pdf | 3/9/2023 | 3/8/2026 |
| Nutrition | Shandong Xinhua Pharmaceutical Co., Ltd. | Nutrition.pdf | 12/4/2024 | 12/4/2027 |
| Irradiation Status Statement | Hebei Guangxiang Pharmaceutical Co. Ltd. | Organic Compliance - 2023-10-12T152547.839.pdf | 9/8/2023 | 9/7/2025 |
| Organic | Hebei Guangxiang Pharmaceutical Co. Ltd. | Organic Compliance - 2023-10-12T152547.839.pdf | 9/8/2023 | 9/7/2025 |
| Pesticide | Hebei Guangxiang Pharmaceutical Co. Ltd. | Organic Compliance - 2023-10-12T152547.839.pdf | 9/8/2023 | 9/7/2025 |
| Organic | CSPC INNOVATION PHARMACEUTICAL | Organic Compliance - 2024-12-06T140809.955.pdf | 6/27/2023 | 6/26/2025 |
| Lot Code | Hebei Guangxiang Pharmaceutical Co. Ltd. | Packaging Declaration - 2023-07-12T161602.119.pdf | 1/27/2023 | 1/26/2026 |
| Lot Code | CSPC INNOVATION PHARMACEUTICAL | Packaging Declaration - 2024-05-20T093854.560.pdf | 3/8/2024 | 3/8/2027 |
| Food Contact Packaging Certificate of Compliance | CSPC INNOVATION PHARMACEUTICAL | Packaging Declaration - 2024-07-12T160725.278.pdf | 3/8/2024 | 3/8/2026 |
| Lot Code | Shandong Xinhua Pharmaceutical Co., Ltd. | Packaging Declaration - 2024-11-13T112255.135.pdf | 9/13/2022 | 9/12/2025 |
| Label Sample | CSPC INNOVATION PHARMACEUTICAL | Packaging Declaration - 2025-04-09T110033.463.pdf | 4/9/2025 | 4/9/2026 |
| California Prop. 65 | CSPC INNOVATION PHARMACEUTICAL | Product Data Sheet - 2024-12-06T130429.672.pdf | 3/6/2024 | 3/6/2026 |
| Ingredient Statement | CSPC INNOVATION PHARMACEUTICAL | Product Data Sheet - 2024-12-06T130429.672.pdf | 3/8/2024 | 3/8/2027 |
| No Animal Ingredient Statement | CSPC INNOVATION PHARMACEUTICAL | Product Data Sheet - 2024-12-06T130429.672.pdf | 3/8/2024 | 3/8/2025 |
| Ingredient Statement | Shandong Xinhua Pharmaceutical Co., Ltd. | Product Data Sheet - 2025-02-17T135713.937.pdf | 9/19/2022 | 9/18/2025 |
| Shelf Life | Shandong Xinhua Pharmaceutical Co., Ltd. | Product Data Sheet - 2025-02-17T135713.937.pdf | 9/19/2022 | 9/18/2025 |
| Ingredient Statement | Hebei Guangxiang Pharmaceutical Co. Ltd. | Product Data Sheet - 2025-03-05T160408.623.pdf | 3/5/2025 | 3/4/2028 |
| California Prop. 65 | Shandong Xinhua Pharmaceutical Co., Ltd. | Product Data Sheet - 2025-03-21T095159.620.pdf | 3/21/2025 | 3/21/2027 |
| Irradiation Status Statement | CSPC INNOVATION PHARMACEUTICAL | Production Process (85).pdf | 3/8/2024 | 3/8/2026 |
| Irradiation Status Statement | Shandong Xinhua Pharmaceutical Co., Ltd. | Production Process (93).pdf | 9/13/2023 | 9/12/2025 |
| Natural | Shandong Xinhua Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2023-08-09T163905.922.pdf | 9/13/2022 | 9/13/2023 |
| BSE - TSE | Shandong Xinhua Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2023-08-18T160412.332.pdf | 9/13/2022 | 9/12/2025 |
| Organic | Shandong Xinhua Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2023-08-24T123109.531.pdf | 9/13/2022 | 9/13/2025 |
| BSE - TSE | Hebei Guangxiang Pharmaceutical Co. Ltd. | Regulatory Information Sheet - 2023-10-12T151221.208.pdf | 1/27/2023 | 1/26/2026 |
| Natural | CSPC INNOVATION PHARMACEUTICAL | Regulatory Information Sheet - 2024-05-20T090847.419.pdf | 3/8/2024 | 3/8/2025 |
| BSE - TSE | CSPC INNOVATION PHARMACEUTICAL | Regulatory Information Sheet - 2024-12-06T114131.786.pdf | 3/8/2024 | 3/8/2027 |
| Label Claims | CSPC INNOVATION PHARMACEUTICAL | Regulatory Information Sheet - 2024-12-06T123045.742.pdf | 3/8/2024 | 3/8/2026 |
| Label Guidance | CSPC INNOVATION PHARMACEUTICAL | Regulatory Information Sheet - 2024-12-06T123045.742.pdf | 3/8/2024 | 3/8/2026 |
| EtO Statement | CSPC INNOVATION PHARMACEUTICAL | Regulatory Information Sheet - 2024-12-06T141954.711.pdf | 3/8/2024 | 3/8/2026 |
| Vegan/Vegetarian Statement | Shandong Xinhua Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2025-02-21T131945.680.pdf | 2/21/2025 | 2/21/2027 |
| No Animal Ingredient Statement | Shandong Xinhua Pharmaceutical Co., Ltd. | Regulatory Information Sheet - 2025-02-21T153940.616.pdf | 2/21/2025 | 2/21/2026 |
| Animal Testing Statement | CSPC INNOVATION PHARMACEUTICAL | Regulatory Information Sheet - 2025-02-28T100034.216.pdf | 2/28/2025 | 2/28/2027 |
| Residual Statement | CSPC INNOVATION PHARMACEUTICAL | Regulatory Information Sheet - 2025-04-09T111012.286.pdf | 4/9/2025 | 4/9/2026 |
| Vegan/Vegetarian Statement | CSPC INNOVATION PHARMACEUTICAL | Regulatory Information Sheet - 2025-05-12T142332.184.pdf | 5/12/2025 | 5/12/2027 |
| Safety Data Sheet (SDS) | CSPC INNOVATION PHARMACEUTICAL | SDS - 2024-05-20T085745.488.pdf | 3/8/2024 | 3/8/2027 |
| Safety Data Sheet (SDS) | Hebei Guangxiang Pharmaceutical Co. Ltd. | SDS - 2025-02-14T154321.378.pdf | 12/22/2023 | 12/21/2026 |
| Safety Data Sheet (SDS) | Shandong Xinhua Pharmaceutical Co., Ltd. | SDS - 2025-02-21T132459.457.pdf | 2/21/2025 | 2/21/2028 |
| Product Specification Sheet | Hebei Guangxiang Pharmaceutical Co. Ltd. | Specification - Factory - 2025-02-14T153441.524.pdf | 12/21/2022 | 12/20/2025 |
| Shelf Life | CSPC INNOVATION PHARMACEUTICAL | Specification - Factory (68).pdf | 11/23/2022 | 11/22/2024 |
| Suitability Requirements | CSPC INNOVATION PHARMACEUTICAL | Suitability Requirements.pdf | 12/2/2022 | 12/1/2025 |
| Suitability Requirements | Hebei Guangxiang Pharmaceutical Co. Ltd. | Suitability Requirements.pdf | 2/15/2023 | 2/14/2026 |
| Suitability Requirements | Shandong Xinhua Pharmaceutical Co., Ltd. | Suitability Requirements.pdf | 11/13/2024 | 11/13/2027 |
| GRAS/NDI/ODI Statement | CSPC INNOVATION PHARMACEUTICAL | US Regulatory Status - 2024-12-06T121137.440.pdf | 12/6/2024 | 12/6/2027 |
| GRAS/NDI/ODI Statement | Shandong Xinhua Pharmaceutical Co., Ltd. | US Regulatory Status - 2025-04-11T150206.389.pdf | 4/11/2025 | 4/10/2028 |
| Product Specification Sheet | Shandong Xinhua Pharmaceutical Co., Ltd. | US SPECIFICATION - 2024-11-13T111651.512.pdf | 11/20/2023 | 11/19/2026 |
| Product Specification Sheet | CSPC INNOVATION PHARMACEUTICAL | US SPECIFICATION - 2024-12-18T160412.867.pdf | 10/1/2023 | 9/30/2026 |
